In this episode of #ExpertAnswers, Dr. Audrey Dubourg and Dr. Gareth Guenigault from CN Bio answer questions from a recent webinar where they explore the value that an organ-on-a-chip approach can bring to drug discovery and development workflows, and how the regulatory landscape is shifting to encourage their widespread adoption.

For more information and to watch the webinar, click here.